Tanegashima, Tokiyoshi
Shiota, Masaki
Toyosaki, Kayo
Funakoshi, Kouta
Eto, Masatoshi
Funding for this research was provided by:
JSPS KAKENHI (24K23360)
Cancer Research Grant from the SGH Foundation
Translational Research Grant of Urological Oncology
Fukuoka Public Health Promotion Organization
Japan Agency for Medical Research and Development (24lk0221196h0001)
Article History
Received: 25 August 2025
Accepted: 30 October 2025
First Online: 6 November 2025
Declarations
:
: MS received honoraria from Janssen Pharmaceutical, AstraZeneca, Astellas Pharma, Sanofi and Bayer Yakuhin and research funding support from Astellas Pharma. ME received honoraria from Ono Pharmaceutical, Takeda Pharmaceutical, Novartis Pharma, Pfizer, Bristol-Myers Squibb, Janssen Pharmaceutical, MSD, Merck Biopharma, AstraZeneca and Eisai, and research funding support from Bayer Yakuhin, Astellas Pharma, Ono Pharmaceutical and Takeda Pharmaceutical.
: Not applicable.
: Not applicable.
: Not applicable.